Emmessar Biotech and Nutrition Limited is an India-based global healthcare company that manufactures and markets healthcare and nutritional products. The Company operates through two segments: Healthcare and Rent on leasehold land. The Company's product portfolio includes dermatology, muscular pains and functions, osteoporosis, general health, anti-ageing, cosmetics, and all types of burns including radiation. Dermatology category includes products for obstinate skin problems. Muscular Pains & Functions category includes solutions for muscle problems. Osteoporosis category includes solutions to bone problems. General Health category includes treatments for various chronic physical ailments. Anti-Ageing category includes products designed to combat the signs of aging. Cosmetics category includes cosmetic products for various skin types. All types of burns, including the radiation category, include treatments for all types of burns, including those caused by radiation.
EMMESSAR BIOTECH & NUTRITION L Financial Highlights
- Revenue: EMMESSAR BIOTECH & NUTRITION L reported revenue of ₹2.41 crore in FY26 vs ₹2.62 crore in FY25. It showed a decrease of 8.02% on a yearly basis.
- Operating Profit: EMMESSAR BIOTECH & NUTRITION L reported an operating profit of ₹0.58 crore in FY26 vs ₹0.96 crore in FY25. It showed a decrease of 39.58% on a year-on-year basis.
- Net Profit: EMMESSAR BIOTECH & NUTRITION L reported a net profit of ₹0.44 crore in FY26 vs ₹0.32 crore in FY25. It showed an increase of 37.50% on a yearly basis.
EMMESSAR BIOTECH & NUTRITION L Quarterly Result Highlights
- EMMESSAR BIOTECH & NUTRITION L reported revenue of ₹0.56 crore in Mar 2026, compared with ₹0.58 crore in Dec 2025, representing a decrease of 3.45% on a quarter-on-quarter (QoQ) basis.
- EMMESSAR BIOTECH & NUTRITION L reported an operating profit of ₹0.08 crore in Mar 2026, compared with ₹0.13 crore in Dec 2025, representing a decrease of 38.46% on a quarter-on-quarter (QoQ) basis.
- EMMESSAR BIOTECH & NUTRITION L reported a profit of ₹0.03 crore in Mar 2026, compared with ₹0.12 crore in Dec 2025, reflecting a decrease of 75.00% on a QoQ basis.
- The earnings per share (EPS) of EMMESSAR BIOTECH & NUTRITION L stood at ₹1.48 during Mar 2026.